The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Fidelity Select Medical Tech and Devcs FSMEX
- NAV / 1-Day Return 64.70 / −0.22 %
- Total Assets 5.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.650%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 42%
USD | NAV as of May 22, 2024 | 1-Day Return as of May 22, 2024, 10:15 PM GMT+0
Morningstar’s Analysis FSMEX
Will FSMEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 68.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Boston Scientific Corp | 13.91 | 821.9 Mil | Healthcare |
Danaher Corp | 13.06 | 771.6 Mil | Healthcare |
Thermo Fisher Scientific Inc | 9.64 | 569.6 Mil | Healthcare |
Intuitive Surgical Inc | 6.92 | 409.1 Mil | Healthcare |
Stryker Corp | 6.06 | 357.9 Mil | Healthcare |
Edwards Lifesciences Corp | 4.35 | 257.1 Mil | Healthcare |
Penumbra Inc | 4.23 | 250.0 Mil | Healthcare |
Abbott Laboratories | 4.00 | 236.4 Mil | Healthcare |
Veeva Systems Inc Class A | 3.59 | 212.0 Mil | Healthcare |
IQVIA Holdings Inc | 2.95 | 174.5 Mil | Healthcare |